Indian vaccine Covaxin has drawn global attention: ICMR

The All India Institute of Medical Sciences (AIIMS) based in New Delhi on December 24 invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.

https://ift.tt/eA8V8J The All India Institute of Medical Sciences (AIIMS) based in New Delhi on December 24 invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites. from Zee News :India National https://ift.tt/3nQb9mD